NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Devices · USD

Lifeward Ltd. (LFWD) Stock Analysis

Lifeward Ltd. (LFWD) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

LFWD

$6.98

−$0.12 (−1.69%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare LFWD with… →

LFWD Key Statistics

As of Sep 4, 2026
Trading
Open
$7.11
Previous Close
$7.10
Day's Range
6.98–7.11
52-Week Range
4.14–10.56
Volume
7.60K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.40
Valuation
Market Cap
$19.77M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.91
EPS (ttm)Profit attributable to each share over the last twelve months.
−14.66
Financials (FY)
Revenue (FY)
$22.03M−14.14%
Net Income (FY)
−$19.91M
Profit marginThe share of revenue left as profit after all costs and taxes.
−141.28%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
2.83M
1-Year Return
+4.43%
Dividend and dates
Earnings Date
November 12, 2026estimated
Avg Volume
9.73K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

LFWD Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+0.81%
2025−66.65%
2024−68.23%
2023+2.37%
2022−38.21%
2021−6.82%
2020−38.89%
2019−50.34%
2018−84.18%
2017−60.71%
2016 (partial year)−56.72%

As of September 4, 2026.

LFWD Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$22.03M−$19.91M−90.4%
2024$25.66M−$28.94M−112.8%
2023$13.85M−$22.13M−159.8%
2022$5.51M−$19.57M−355.1%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$22.03M$8.43M−$16.89M−$19.91M−90.4%
2024$25.66M$8.22M−$19.55M−$28.94M−112.8%
2023$13.85M$4.45M−$23.61M−$22.13M−159.8%
2022$5.51M$1.91M−$19.10M−$19.57M−355.1%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

LFWD Valuation vs Medical Devices Median

Median of 151 stocks
MetricLFWDMedical Devices medianvs median
P/S ratio0.912.980.3x the median
Profit margin−141.28%−1.69%139.6 pts below

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Lifeward Ltd. (LFWD) is capitalised at $19.77M on the latest close. It is classified in the Medical Devices industry, within the Healthcare sector. The company reports 81 employees.

The most recent close on file for LFWD is $6.98, dated September 4, 2026. That is −$0.12 (−1.69%) against the previous close. Over the past 52 weeks the price has ranged from $4.14 to $10.56. The latest close sits 68.6% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $22.03M. Against the prior fiscal year total of $25.66M, that is a change of −14.14%. The same year closed with a net loss of $19.91M. Profit margin runs at −141.28%. That is 139.6 percentage points below the Medical Devices median of −1.69%. Trailing earnings per share are −14.66.

Across the 4 fiscal years on file, revenue moves from $5.51M in 2022 to $22.03M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The price-to-sales ratio is 0.91. On price-to-sales that is 0.3 times the Medical Devices median of 2.98. The medians here are taken across 151 Medical Devices companies that report the metric.

Over the trailing twelve months the price has returned +4.43%. Across 10 years the annualized return works out at −52.68%. Beta against the wider market is reported at 0.4. Annualized volatility over the trailing 10 years is 108.33%.

Growth & Income

No dividend is on file for LFWD.

So far in 2026 the price is +0.81%. The strongest complete calendar year on file is 2023 at +2.37%; the weakest is 2018 at −84.18%. Of the 9 complete calendar years on file, 1 finished higher.

Peer Comparison

Lifeward Ltd. (LFWD) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Lifeward Ltd. LFWD $19.77M —
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. Lifeward Ltd. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

 MDT

Medtronic plc.

$120.46B

 SYK

Stryker Corporation

$116.27B

 BSX

Boston Scientific Corporation

$69.27B

 EW

Edwards Lifesciences Corporation

$51.82B

 DXCM

DexCom, Inc.

$33.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Lifeward Ltd.

Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Germany, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices for individuals with spinal cord injury; ReStore Exo-Suit, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals' post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as ReWalk Robotics Ltd. and changed its name to Lifeward Ltd. in September 2024. Lifeward Ltd. was incorporated in 2001 and is based in Yokneam Illit, Israel.

Visit website →